{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:40:36Z","timestamp":1761514836626,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["PO1 HL149626"],"award-info":[{"award-number":["PO1 HL149626"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bcmd.2021.102627","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T07:00:25Z","timestamp":1637132425000},"page":"102627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Prognostic factors associated with COVID-19 related severity in sickle cell disease"],"prefix":"10.1016","volume":"92","author":[{"given":"Nalan","family":"Yurtsever","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonah","family":"Ziemba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bcmd.2021.102627_bb0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1182\/bloodadvances.2020003456","article-title":"Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection","volume":"5","author":"Minniti","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.bcmd.2021.102627_bb0010","first-page":"1","article-title":"Incidence rate of COVID-19 infection in hemoglobinopathies: a systematic review and meta-analysis","author":"Haghpanah","year":"2021","journal-title":"Hemoglobin"},{"issue":"1","key":"10.1016\/j.bcmd.2021.102627_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.htct.2020.11.002","article-title":"Hemoglobinopathy and pediatrics in the time of COVID-19","volume":"43","author":"Vilela","year":"2021","journal-title":"Hematol. Transfus Cell Ther."},{"issue":"7","key":"10.1016\/j.bcmd.2021.102627_bb0020","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1182\/bloodadvances.2020003741","article-title":"COVID-19 in individuals with sickle cell disease\/trait compared with other black individuals","volume":"5","author":"Singh","year":"2021","journal-title":"Blood Adv."},{"issue":"10","key":"10.1016\/j.bcmd.2021.102627_bb0025","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.3201\/eid2610.202792","article-title":"Coronavirus disease among persons with sickle cell disease, United States, March 20-May 21, 2020","volume":"26","author":"Panepinto","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.bcmd.2021.102627_bb0030","doi-asserted-by":"crossref","DOI":"10.7326\/M21-1375","article-title":"Sickle cell disorders and severe COVID-19 outcomes: a cohort study","author":"Clift","year":"2021","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102627_bb0035","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2020.046","article-title":"Preliminary data on COVID-19 in patients with hemoglobinopathies: a multicentre ICET-A study","volume":"12","author":"de Sanctis","year":"2020","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"journal-title":"Haematologica","year":"2021","author":"Hoogenboom","key":"10.1016\/j.bcmd.2021.102627_bb0040"},{"issue":"8","key":"10.1016\/j.bcmd.2021.102627_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29075","article-title":"Sickle cell disease and COVID-19: susceptibility and severity","volume":"68","author":"Sayad","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"13","key":"10.1016\/j.bcmd.2021.102627_bb0050","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/bloodadvances.2021004288","article-title":"Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease","volume":"5","author":"Mucalo","year":"2021","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102627_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/rmv.2146","article-title":"Predictors of COVID-19 severity: a literature review","volume":"31","author":"Gallo Marin","year":"2021","journal-title":"Rev. Med. Virol."},{"issue":"4","key":"10.1016\/j.bcmd.2021.102627_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9040941","article-title":"Novel coronavirus infection (COVID-19) in humans: a scoping review and meta-analysis","volume":"9","author":"Borges do Nascimento","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.bcmd.2021.102627_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/aje\/kwaa191","article-title":"COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes","volume":"190","author":"Gomez-Ochoa","year":"2021","journal-title":"Am. J. Epidemiol."},{"issue":"43","key":"10.1016\/j.bcmd.2021.102627_bb0070","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.15585\/mmwr.mm6943e3","article-title":"COVID-19-associated hospitalizations among health care personnel - COVID-NET, 13 states, March 1-May 31, 2020","volume":"69","author":"Kambhampati","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.bcmd.2021.102627_bb0075","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.63195","article-title":"A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study","volume":"9","author":"Linssen","year":"2020","journal-title":"elife"},{"key":"10.1016\/j.bcmd.2021.102627_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.167","article-title":"Mild anemia as a single independent predictor of mortality in patients with COVID-19","author":"Tremblay","year":"2021","journal-title":"EJHaem"},{"issue":"1","key":"10.1016\/j.bcmd.2021.102627_bb0085","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1038\/s41467-020-19080-6","article-title":"Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19","volume":"11","author":"Carissimo","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bcmd.2021.102627_bb0090","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1182\/blood-2007-04-084921","article-title":"A network model to predict the risk of death in sickle cell disease","volume":"110","author":"Sebastiani","year":"2007","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bcmd.2021.102627_bb0095","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.bcmd.2021.102627_bb0100","first-page":"4","article-title":"Differences in the clinical and genotypic presentation of sickle cell disease around the world","volume":"15","author":"Saraf","year":"2014","journal-title":"Paediatr. Respir. Rev."},{"issue":"9","key":"10.1016\/j.bcmd.2021.102627_bb0105","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1016\/S2352-3026(20)30204-0","article-title":"Prognosis of patients with sickle cell disease and COVID-19: a french experience","volume":"7","author":"Arlet","year":"2020","journal-title":"Lancet Haematol."},{"issue":"1","key":"10.1016\/j.bcmd.2021.102627_bb0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33706","article-title":"Estimation of US SARS-CoV-2 infections, symptomatic infections, hospitalizations, and deaths using seroprevalence surveys","volume":"4","author":"Angulo","year":"2021","journal-title":"JAMA Netw. Open"},{"issue":"10","key":"10.1016\/j.bcmd.2021.102627_bb0115","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.7326\/M21-1991","article-title":"Clinical trends among U.S. Adults hospitalized with COVID-19, March to December 2020: a cross-sectional study","volume":"174","author":"Garg","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bcmd.2021.102627_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/jha2.195","article-title":"In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: a retrospective study","author":"Al-Jarallah","year":"2021","journal-title":"EJHaem"},{"key":"10.1016\/j.bcmd.2021.102627_bb0125","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajem.2021.03.083","article-title":"On-admission anemia predicts mortality in COVID-19 patients: a single center, retrospective cohort study","volume":"48","author":"Oh","year":"2021","journal-title":"Am. J. Emerg. Med."},{"issue":"2","key":"10.1016\/j.bcmd.2021.102627_bb0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood.2020004853","article-title":"Plasma microparticles of sickle patients during crisis or taking hydroxyurea modify endothelium inflammatory properties","volume":"136","author":"Garnier","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcmd.2021.102627_bb0135","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1111\/bjh.17650","article-title":"Hydroxyurea therapy decreases coagulation and endothelial activation in sickle cell disease: a longitudinal study","volume":"194","author":"Elsherif","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2021.102627_bb0140","article-title":"Effects of hydroxyurea on cytotoxicity, inflammation and oxidative stress markers in neutrophils of patients with sickle cell anemia: dose-effect relationship","author":"Pedrosa","year":"2020","journal-title":"Hematol. Transfus Cell Ther."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979621000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:36:59Z","timestamp":1761050219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979621000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":28,"alternative-id":["S1079979621000930"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102627","relation":{},"ISSN":["1079-9796"],"issn-type":[{"type":"print","value":"1079-9796"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic factors associated with COVID-19 related severity in sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2021.102627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102627"}}